Search research articles
Contact Us
Filters
Showing results (141-150 of 282) with videos related to
Page
of 29
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Tim R Cressey, Hannah Green, Saye Khoo, et al.
Frontiers in Pharmacology
|
February 14, 2022
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease
Maiara Camotti Montanha, Nicolas Cottura, Michael Booth, et al.
AIDS Research and Human Retroviruses
|
October 31, 2003
Ketoconazole and lopinavir/ritonavir coadministration: boosting beyond boosting
Marta Boffito, Stefano Bonora, Paola Sales, et al.
BMC Health Services Research
|
August 3, 2020
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
Yussif Alhassan, Adelline Twimukye, Thoko Malaba, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2018
Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites
Eric H Decloedt, Phumla Z Sinxadi, Gert U van Zyl, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2020
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics
Emilie R Elliot, Megan Neary, Laura Else, et al.
British Journal of Clinical Pharmacology
|
November 25, 2018
Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?
Sa'ad T Abdullahi, Adeniyi Olagunju, Julius O Soyinka, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2022
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease
José Moltó, Fredzzia Graterol, Adrian Curran, et al.
BMC Public Health
|
December 8, 2020
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
Yussif Alhassan, Adelline Twimukye, Thoko Malaba, et al.
AIDS (London, England)
|
April 7, 2007
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy
Ben Kikaire, Saye Khoo, A Sarah Walker, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 282) with videos related to
Sort By:
Page
of 29
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 19, 2008
Plasma drug concentrations and virologic evaluations after stopping treatment with nonnucleoside reverse-transcriptase inhibitors in HIV type 1-infected children
Tim R Cressey, Hannah Green, Saye Khoo, et al.
Frontiers in Pharmacology
|
February 14, 2022
PBPK Modelling of Dexamethasone in Patients With COVID-19 and Liver Disease
Maiara Camotti Montanha, Nicolas Cottura, Michael Booth, et al.
AIDS Research and Human Retroviruses
|
October 31, 2003
Ketoconazole and lopinavir/ritonavir coadministration: boosting beyond boosting
Marta Boffito, Stefano Bonora, Paola Sales, et al.
BMC Health Services Research
|
August 3, 2020
Engendering health systems in response to national rollout of dolutegravir-based regimens among women of childbearing potential: a qualitative study with stakeholders in South Africa and Uganda
Yussif Alhassan, Adelline Twimukye, Thoko Malaba, et al.
The Journal of Antimicrobial Chemotherapy
|
December 12, 2018
Pharmacogenetics and pharmacokinetics of CNS penetration of efavirenz and its metabolites
Eric H Decloedt, Phumla Z Sinxadi, Gert U van Zyl, et al.
The Journal of Antimicrobial Chemotherapy
|
February 4, 2020
Genetic influence of ABCG2, UGT1A1 and NR1I2 on dolutegravir plasma pharmacokinetics
Emilie R Elliot, Megan Neary, Laura Else, et al.
British Journal of Clinical Pharmacology
|
November 25, 2018
Pharmacogenetics of artemether-lumefantrine influence on nevirapine disposition: Clinically significant drug-drug interaction?
Sa'ad T Abdullahi, Adeniyi Olagunju, Julius O Soyinka, et al.
The Journal of Antimicrobial Chemotherapy
|
April 15, 2022
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease
José Moltó, Fredzzia Graterol, Adrian Curran, et al.
BMC Public Health
|
December 8, 2020
Community acceptability of dolutegravir-based HIV treatment in women: a qualitative study in South Africa and Uganda
Yussif Alhassan, Adelline Twimukye, Thoko Malaba, et al.
AIDS (London, England)
|
April 7, 2007
Nevirapine clearance from plasma in African adults stopping therapy: a pharmacokinetic substudy
Ben Kikaire, Saye Khoo, A Sarah Walker, et al.
Page
of 29